Please provide your email address to receive an email when new articles are posted on . Horizon Therapeutics recently announced new MRI imaging data from a phase 3 clinical trial, which demonstrated ...
Patients with type 2 diabetes (T2D) on semaglutide or tirzepatide showed a higher incidence of nonarteritic anterior ischemic optic neuropathy and other optic nerve disorders compared to other ...
When your optic nerve doesn’t develop all the way, you may not be able to see through that area of your eye. This congenital condition is most often experienced by people who have mothers with ...
Other symptoms in NMOSD occur in CNS areas besides the optic nerve and spinal cord, including intractable nausea, vomiting, and intractable hiccups in area postrema syndrome (APS, a specific brainstem ...
About The Study: In this study of patients with type 2 diabetes who had no prior eye disorders, patients prescribed semaglutide or tirzepatide had an increased risk of nonarteritic anterior ischemic ...
SIOUX FALLS, SD – November 04, 2025 – PRESSADVANTAGE – Glaucoma remains one of the leading causes of blindness in the United States, often progressing silently until vision loss has already occurred.
Prevent Blindness, the nation's leading patient advocacy organization dedicated to preventing blindness and preserving sight, ...
Changes in the optic disc can predict who will develop blind spots in their vision or lose sharpness of vision from ...
New research has discovered certain weight-loss medications could be associated with an increased risk of serious eye conditions, and even vision loss. Two studies, published in JAMA, analyzed how ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback